K Soares-Weiser

Summary

Country: Israel

Publications

  1. ncbi Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials
    K Soares-Weiser
    Dept of Medicine E, Beilinson Campus, Rabin Medical Center, Petah Tikva, Israel
    Scand J Gastroenterol 38:193-200. 2003
  2. pmc Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis
    K Soares-Weiser
    Department of Medicine E, Rabin Medical Center, Petah Tikva, Israel
    BMJ 324:100-2. 2002
  3. ncbi Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2000
  4. ncbi Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding
    K Soares-Weiser
    Department of Medicine E, Rabin Medical Center Beilinson Campus, Petah Tikva, Israel, 41900
    Cochrane Database Syst Rev . 2002
  5. ncbi Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia
    K Soares-Weiser
    Bar llan University, Department of Social Work, 82 Jerusalem Street, Kfar Saba, Tel Aviv, Israel, 44365
    Cochrane Database Syst Rev . 2006
  6. ncbi Vitamin E for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2001
  7. ncbi Antibiotics for spontaneous bacterial peritonitis in cirrhotics
    K Soares-Weiser
    Department of Internal Medicine E, Rabin Medical Center Beilinson Campus, Petah Tikva, Israel, 41900
    Cochrane Database Syst Rev . 2001
  8. ncbi Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
    K V Soares
    Department of Internal Medicine E, Rabin Medical Center, Beilison Campus, Petah Tikva, Israel, 49000
    Cochrane Database Syst Rev . 2001
  9. ncbi Calcium channel blockers for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2001
  10. ncbi Vitamin E for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2000

Collaborators

Detail Information

Publications17

  1. ncbi Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials
    K Soares-Weiser
    Dept of Medicine E, Beilinson Campus, Rabin Medical Center, Petah Tikva, Israel
    Scand J Gastroenterol 38:193-200. 2003
    ..We performed a systematic review to evaluate the efficacy of antibiotic prophylaxis in inpatients with cirrhosis, regardless of the underlying risk factors that led to hospital admission...
  2. pmc Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis
    K Soares-Weiser
    Department of Medicine E, Rabin Medical Center, Petah Tikva, Israel
    BMJ 324:100-2. 2002
  3. ncbi Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2000
    ..The gamma-aminobutyric acid (GABA) agonist drugs have been trialed as a treatment for TD, but these drugs have intense sedative properties and can possibly exacerbate psychotic symptoms...
  4. ncbi Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding
    K Soares-Weiser
    Department of Medicine E, Rabin Medical Center Beilinson Campus, Petah Tikva, Israel, 41900
    Cochrane Database Syst Rev . 2002
    ..Antibiotic prophylaxis seems to decrease the incidence of bacterial infections. Oral antibiotics, active against enteric bacteria, have been most often used as antibiotic prophylaxis in cirrhotic patients with gastrointestinal bleeding...
  5. ncbi Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia
    K Soares-Weiser
    Bar llan University, Department of Social Work, 82 Jerusalem Street, Kfar Saba, Tel Aviv, Israel, 44365
    Cochrane Database Syst Rev . 2006
    ..Various strategies have been examined to reduce a person's cumulative exposure to neuroleptics. These studies include dose reduction, intermittent dosing strategies such as drug holidays, and neuroleptic cessation...
  6. ncbi Vitamin E for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2001
    ..However, it is associated with a wide range of adverse effects, including movement disorders such as tardive dyskinesia (TD). Vitamin E has been proposed as a treatment to prevent or decrease the severity of TD...
  7. ncbi Antibiotics for spontaneous bacterial peritonitis in cirrhotics
    K Soares-Weiser
    Department of Internal Medicine E, Rabin Medical Center Beilinson Campus, Petah Tikva, Israel, 41900
    Cochrane Database Syst Rev . 2001
    ..However, this recommendation is not based on convincing evidence. It has been proposed that treatment should cover Gram-negative enteric bacteria and Gram-positive cocci, that are responsible for up to 90% of cases...
  8. ncbi Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
    K V Soares
    Department of Internal Medicine E, Rabin Medical Center, Beilison Campus, Petah Tikva, Israel, 49000
    Cochrane Database Syst Rev . 2001
    ..The gamma-aminobutyric acid (GABA) agonist drugs have been trialed as a treatment for TD, but these drugs have intense sedative properties and may exacerbate psychotic symptoms...
  9. ncbi Calcium channel blockers for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2001
    ....
  10. ncbi Vitamin E for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2000
    ..However, it is associated with a wide range of adverse effects, including movement disorders such as tardive dyskinesia (TD). Vitamin E has been proposed as a treatment to prevent or decrease the severity of TD...
  11. ncbi Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2000
    ....
  12. ncbi Anticholinergic medication for neuroleptic-induced tardive dyskinesia
    K V Soares
    Dov Hoz Street, 27 16, Kfar Saba, Israel, 44356
    Cochrane Database Syst Rev . 2000
    ..Because of this, many acutely psychotic patients being treated with neuroleptic medication also receive anticholinergic drugs in order to reduce some of the associated movement side-effects...
  13. ncbi Miscellaneous treatments for neuroleptic-induced tardive dyskinesia
    K V Soares-Weiser
    Department of Internal Medicine E, Rabin Medical Center, Beilison Campus, Petah Tikva, Israel, 49000
    Cochrane Database Syst Rev . 2003
    ..This review, one in a series examining the treatment of tardive dyskinesia, will cover miscellaneous treatments not covered elsewhere...
  14. ncbi Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia
    M Paul
    Infectious Diseases Unit, Rabin Medical Center Beilison Campus, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev . 2002
    ..Early, empirical antibiotic treatment is therefore administered routinely to febrile neutropaenic patients. Currently, either beta-lactam-aminoglycoside combination treatment or beta-lactam monotherapy are recommended...
  15. ncbi Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
    L Vidal
    Department of Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev . 2004
    ..The common practice is to admit the patient to hospital and treat empirically with intravenous broad-spectrum antibiotics. Oral therapy could be an alternative approach for selected patients...
  16. ncbi Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
    M Paul
    Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev . 2006
    ..Optimal antibiotic treatment for sepsis is imperative. Combining a beta-lactam antibiotic with an aminoglycoside antibiotic may have certain advantages over beta-lactam monotherapy...
  17. ncbi Benzodiazepines for neuroleptic-induced tardive dyskinesia
    P S Bhoopathi
    Academic Unit of Psychiatry, 15, Hyde Terrace, Leeds, West Yorkshire, UK LS2 9LT
    Cochrane Database Syst Rev . 2006
    ....